MyAverix Finance
HK · Healthcare
Jiangsu Recbio Technology Co Ltd (2179)
Biotechnology
Jiangsu Recbio Technology Co Ltd (2179) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $3.22B, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 2179
Jiangsu Recbio Technology Co Ltd (2179) — FAQ
What is Jiangsu Recbio Technology Co Ltd's market cap?
Jiangsu Recbio Technology Co Ltd (2179) has a reported market cap of $3.22B (data as of 2026-05-21).
What is 2179's P/E ratio?
The price-to-earnings (P/E) ratio for Jiangsu Recbio Technology Co Ltd (2179) is 18.00 (data as of 2026-05-21).
Does Jiangsu Recbio Technology Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for Jiangsu Recbio Technology Co Ltd (2179). Check the MyAverix Finance app for the latest dividend data.
What sector is Jiangsu Recbio Technology Co Ltd in?
Jiangsu Recbio Technology Co Ltd (2179) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 2179 listed on?
2179 is listed on HK.
What is Jiangsu Recbio Technology Co Ltd's net margin?
Jiangsu Recbio Technology Co Ltd (2179) reports a net margin of 0.0% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.